Latest News in the pharma Industry

Research & Development

New Cosentyx data look promising for patients with scalp psoriasis

New Cosentyx data look promising for patients with scalp psoriasis

21 Feb 2018

Majority of patients with scalp psoriasis on Cosentyx (secukinumab) achieved clear skin at Weeks 12 and 24 and improved quality of life.

Read more 
Lonza to establish cell- and gene-therapy Centers of Excellence to accelerate growth

Lonza to establish cell- and gene-therapy Centers of Excellence to accelerate growth

20 Feb 2018

The Centers of Excellence will allow custoners to access customer-centric solutions.

Read more 
Expanded GXP compliance increases Concept's breadth of services

Expanded GXP compliance increases Concept's breadth of services

9 Feb 2018

Successful MHRA inspection at Dundee site confirms GLP accreditation for in vitro safety studies and bioanalysis.

Read more 
'Effective' hair loss treatment candidate advances to Phase IIa

'Effective' hair loss treatment candidate advances to Phase IIa

7 Feb 2018

German Medicines Agency sees potential in FOL-005 - a modified version of the endogenous protein, osteopontin - the green light for further studies.

Read more 
Metrion Biosciences awarded £200k funding to further develop in-house drug discovery pipeline

Metrion Biosciences awarded £200k funding to further develop in-house drug discovery pipeline

6 Feb 2018

Funding will support further development of recently acquired small molecule assets for treatment of autoimmune disease.

Read more 
Lab automation systems for faster scientific breakthroughs

Lab automation systems for faster scientific breakthroughs

5 Feb 2018

PAA showcases its complete range of automation solutions, suitable for any type of laboratory or application, at SLAS2018.

Read more 
Sanofi, DNDi seek EMA review for sleeping sickness treatment

Sanofi, DNDi seek EMA review for sleeping sickness treatment

1 Feb 2018

Fexinidazole would be first all-oral treatment under investigation for both first and second stages of sleeping sickness, a fatal disease, endemic in Africa.

Read more 
Collaboration expanded to explore synthetically feasible chemical space

Collaboration expanded to explore synthetically feasible chemical space

25 Jan 2018

Enamine REAL database of synthetic compounds accessible via UCSF’s online ZINC platform.

Read more 
Partnership in AI and machine learning for target discovery

Partnership in AI and machine learning for target discovery

23 Jan 2018

LifeArc and Milner Therapeutics Institute to develop, validate and integrate cutting-edge machine learning approaches into drug discovery processes.

Read more 
Charles River acquisition enhances discovery expertise

Charles River acquisition enhances discovery expertise

18 Jan 2018

KWS increases Charles River's ability to support clients’ early-stage drug research in critical therapeutic areas.

Read more 
2017: A year of innovation and advances

2017: A year of innovation and advances

14 Jan 2018

A summary and highlights of new drug therapy approvals and other drug therapy advances in 2017 by FDA's CDER.

Read more 
New automated VPT systems for topical drug performance testing

New automated VPT systems for topical drug performance testing

11 Jan 2018

The MedStat-HT and MedFlux-HT help to de-risk development programs and shorten development timelines.

Read more